Cargando…
Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection
Bictegravir is a new integrase strand transfer inhibitor (INSTI) with a high genetic barrier to the development of HIV-1 resistance. The drug is co-formulated with the nucleos(t)ide reverse transcriptase inhibitors emtricitabine and tenofovir alafenamide (AF) in a single-tablet regimen (STR) for the...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424950/ https://www.ncbi.nlm.nih.gov/pubmed/30460547 http://dx.doi.org/10.1007/s40265-018-1010-7 |